Colorectal Cancer Clinical Trial
— PrehabOfficial title:
Prehabilitation Interventions in Elective Colorectal Resections: A Randomized Pilot Study (Prehab)
This is a pilot study designed to evaluate a programme of rehabilitation for patients undergoing elective colorectal resection surgery.
Status | Recruiting |
Enrollment | 70 |
Est. completion date | September 2017 |
Est. primary completion date | September 2017 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - adult patient - scheduled to undergo a colorectal resection as part of treatment for colorectal cancer. - English speaking or have available a family member or substitute decision maker who can accompany you to all of your study visits. Exclusion Criteria: - geographic inaccessibility - unwilling to provide consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Canada | St Joseph Healthcare Hamilton | Hamilton | Ontario |
Lead Sponsor | Collaborator |
---|---|
McMaster University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of participants recruiting | Screening and recruiting of eligible patients | 6 months | No |
Secondary | Post-op complications | Post-op complications by Clavien-Dindo classification (pulmonary, DVT, MI) Completed by surgical team during admission, discharge and 30 days | 30 days | No |
Secondary | Mortality | Survival will be noted at completion of 6 month study period. | 6 months | No |
Secondary | Length of Stay | Length of stay in hospital will be collected and compared for the two treatment groups | 30 days post-op | No |
Secondary | Number of patients with readmissions | Number of patients with readmission to hospital during the 30 day and 6 month period will be compared for the two treatment groups | 30 days and 6 months | No |
Secondary | Physical Function Assessment (6 Minute Walk Test) | 6 Minute Walk Test (6MWT) | 1, 3 and 6 months | No |
Secondary | Symptom Assessment (Edmonton Symptom Assessment System) | Edmonton Symptom Assessment System (ESAS) | 1, 3 and 6 months | No |
Secondary | Functional Independence Assessment (UK Functional Independence Measure and Functional Assessment Measure) | UK Functional Independence Measure and Functional Assessment Measure (UK FIM+FAM) | 1, 3 and 6 months | No |
Secondary | Quality of Life Survey (Short Form 36 Health Survey) | Short Form 36 Health Survey (SF-36) | 1, 3 and 6 months | No |
Secondary | Pain Assessment (Visual Analog Scale) | Pain score by Visual Analog Scale | 1, 3 and 6 months | No |
Secondary | Bowel Function Assessment | Bowel Function Index | 1, 3 and 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Not yet recruiting |
NCT05775146 -
SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases
|
Phase 2 | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 |